z-logo
open-access-imgOpen Access
The angiotensin II type 2 receptor in the brain
Author(s) -
Masatsugu Horiuchi,
Masaki Mogi,
Masaru Iwai
Publication year - 2009
Publication title -
journal of the renin-angiotensin-aldosterone system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 46
eISSN - 1752-8976
pISSN - 1470-3203
DOI - 10.1177/1470320309347793
Subject(s) - angiotensin ii , receptor , renin–angiotensin system , angiotensin receptor , medicine , angiotensin ii receptor type 1 , neurogenesis , stroke (engine) , endocrinology , neuroscience , pharmacology , biology , blood pressure , mechanical engineering , engineering
Recent clinical studies indicate that blockade of the renin-angiotensin system is important to prevent stroke, and accumulating results of basic research also indicate the possible involvement of the central renin-angiotensin system in ischaemic brain damage and cognition. When the angiotensin II type 1 receptor is blocked by an angiotensin type 1 receptor blocker, unbound angiotensin II acts preferentially on the angiotensin II type 2 (AT 2 ) receptor. These results suggest the pathophysiological importance of the AT 2 receptor in the clinical use of angiotensin type 1 receptor blockers, which are widely used in patients with hypertension with the expectation of a decrease in the onset of cardiovascular and cerebrovascular disease. We review here the possible roles of AT 2 receptor activation in the brain, focusing on ischaemic stroke, cognitive function and neurogenesis, and potential effects of specific AT 2 receptor agonists.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom